Related Experiment Video
Updated: Jan 22, 2026

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Published on: February 22, 2019
Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological
Nikolas G Balanis1, Katherine M Sheu1, Favour N Esedebe1
1Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA 90095, USA.
Abstract:
Small-cell neuroendocrine cancers (SCNCs) are an aggressive cancer subtype. Transdifferentiation toward an SCN phenotype has been reported as a resistance route in response to targeted therapies. Here, we identified a convergence to an SCN state that is widespread across epithelial cancers and is associated with poor prognosis. More broadly, non-SCN metastases have higher expression of SCN-associated transcription factors than non-SCN primary tumors. Drug sensitivity and gene dependency screens demonstrate that these convergent SCNCs have shared vulnerabilities. These common vulnerabilities are found across unannotated SCN-like epithelial cases, small-round-blue cell tumors, and unexpectedly in hematological malignancies. The SCN convergent phenotype and common sensitivity profiles with hematological cancers can guide treatment options beyond tissue-specific targeted therapies.
Insights
Small-cell neuroendocrine cancers (SCNCs) can arise in many epithelial cancers, presenting a poor prognosis. These cancers share vulnerabilities with hematological malignancies, suggesting broader treatment strategies.
Area of Science:
- Oncology
- Cancer Biology
- Genetics
Background:
- Small-cell neuroendocrine cancers (SCNCs) are aggressive and can emerge as a resistance mechanism to targeted therapies.
- Transdifferentiation towards a small-cell neuroendocrine phenotype is a known route for cancer cells to evade treatment.
Purpose of the Study:
- To investigate the prevalence and implications of a convergent small-cell neuroendocrine cancer state across various epithelial cancers.
- To identify shared vulnerabilities and potential therapeutic targets in these convergent cancers.
Main Methods:
- Analysis of gene expression data to identify SCN-associated transcription factors in primary tumors and metastases.
- Drug sensitivity and gene dependency screens to uncover common vulnerabilities in SCN-like cancers.
Main Results:
- A convergent small-cell neuroendocrine cancer state is widespread across epithelial cancers and linked to poor outcomes.
- Metastases exhibit higher expression of SCN-associated transcription factors compared to primary tumors.
- Convergent SCNCs, including unannotated SCN-like and small-round-blue cell tumors, share vulnerabilities with hematological malignancies.
Conclusions:
- The convergent small-cell neuroendocrine phenotype represents a common pathway in epithelial cancers with significant prognostic implications.
- Identified shared vulnerabilities between SCNCs and hematological cancers offer novel therapeutic avenues beyond tissue-specific treatments.
More Related Videos
12:04Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
08:33Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells
Published on: April 25, 2014
Related Concept Videos
Convergent Evolution
Region of Convergence
Convergence of Fourier Series
The Gibbs phenomenon refers to the persistent oscillations and overshoots that occur near discontinuities...
Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...
Region of Convergence of Laplace Tarnsform
Consider a decaying exponential signal that begins at a specific time. When deriving its Laplace transform, the time-domain variable is replaced with a complex variable. This...
Susceptibility, Permittivity and Dielectric Constant